45.74
0.46 (1.02%)
| Previous Close | 45.28 |
| Open | 45.20 |
| Volume | 122,299 |
| Avg. Volume (3M) | 416,950 |
| Market Cap | 1,315,647,104 |
| Price / Sales | 7.27 |
| Price / Book | 23.22 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2025 - 3 Mar 2025 |
| Profit Margin | -50.95% |
| Operating Margin (TTM) | -41.94% |
| Diluted EPS (TTM) | -3.00 |
| Quarterly Revenue Growth (YOY) | 41.00% |
| Total Debt/Equity (MRQ) | 421.47% |
| Current Ratio (MRQ) | 3.56 |
| Operating Cash Flow (TTM) | -64.97 M |
| Levered Free Cash Flow (TTM) | -53.42 M |
| Return on Assets (TTM) | -10.15% |
| Return on Equity (TTM) | -236.66% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Establishment Labs Holdings Inc | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 2.0 |
| Average | 0.63 |
|
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 11.29% |
| % Held by Institutions | 106.24% |
| 52 Weeks Range | ||
| Median | 52.00 (13.69%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Stephens & Co. | 06 Mar 2025 | 52.00 (13.69%) | Buy | 42.88 |
| 27 Feb 2025 | 52.00 (13.69%) | Buy | 42.53 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 06 Mar 2025 | Announcement | Establishment Labs® Announces Meghan Trainor as Brand Partner Following Her Breast Augmentation with Motiva Implants® |
| 26 Feb 2025 | Announcement | Establishment Labs Reports Fourth Quarter and Full Year 2024 Financial Results and Reaffirms 2025 Guidance |
| 25 Feb 2025 | Announcement | Establishment Labs to Present at TD Cowen's 45th Annual Health Care Conference |
| 21 Feb 2025 | Announcement | Establishment Labs to Present at Citi’s 2025 Unplugged Medtech and Life Sciences Access Day |
| 18 Feb 2025 | Announcement | Establishment Labs Launches Preservé™ |
| 14 Feb 2025 | Announcement | Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26 |
| 13 Jan 2025 | Announcement | Establishment Labs Announces CEO Transition |
| 07 Jan 2025 | Announcement | Establishment Labs to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |